Mediscience Technology and Collaborators’

Commercialization Execution

Infotonics Technology Corp.
Shareholder in Mediscience

Commercialization Collaborator

Infotonics is a collaborative, industry-leading microsystems R&D center that drives economic growth and creates high-technology businesses from its position as a worldleader in photonics and microsystems innovation and commercialization.

• In-house services and capabilities to develop devices, accelerating time to market. Unlike many foundries and academic labs, Infotonics’ expert scientific and business staff, average over 20 years industry experience, works with Mediscience from design and simulation through fabrication to packaging and test; demonstrate reliability and
  insure manufacturability.
• Design & Simulation
• Rapid Prototyping
• Packaging
• Test and Metrology
• Pilot Production
• Low Volume Production
• Technology Transfer

City University of New York
Shareholder in Mediscience

Center for Advanced Technology (CAT)
Scientific Discovery, Research & Development Collaborator

• The CAT conducts high level research in areas related to the development of products and processes using light enabled technologies. These include: optical medical diagnostics, optical imaging, tunable solid state lasers, ultrafast laser technology, optical semiconductor materials and devices, nanoscale photonic materials and devices, compact photonic devices, optical communications, biological sensing and processes, optical computing and optical bio-defense.

• Led by Professor Robert R. Alfano, Distinguished Professor of Science & Engineering for the Institute of Ultrafast Spectroscopy and Lasers and his staff of researchers; Prof. Alfano’s research interests are rooted in biomedical imaging and spectroscopy, ultrafast lasers and optics, tunable lasers, semiconductor materials and devices, optical materials, biophysics, nonlinear optics and photonics.

• Alfano is a shareholder of Mediscience; Chairman of the Mediscience Scientific Advisory Group; possesses 84 patents, including the “Stokes-Shift Spectroscopy for Detection of Disease and Physiological State of Specimen", has been cited in over 600 journals; and received 150 grant awards totaling $44 million.

Schiff & Company

Clinical Research and Regulatory Affairs

• Schiff & Company, founded in 1982, is an international Regulatory Affairs and Clinical Research Organization. Senior Management personnel each have more than 25 years experience in the health care and FDA regulatory fields.

• Schiff & Company will conduct and monitor clinical studies for Mediscience diagnostic devices. Schiff represent both domestic and international organizations to the FDA and to foreign regulatory bodies. Will write all appropriate regulatory filings.

• Schiff staff plans regulatory strategy, prepares clinical development plans, performs GMP and validation audits, writes SOP’s and conducts due diligence.